D. Price (Aberdeen, United Kingdom), N. Chavannes (Rotterdam, Netherlands)
Impact of a spirometry expert system on general practitioners‘ decision-making when diagnosing chronic respiratory disease: a cluster-randomised trial
P. Poels, D. Schellekens, T. Schermer, R. Akkermans, P. de Vries Robbe, A. Kaplan, B. Bottema, C. van Weel (Nijmegen, Netherlands; Ontario, Canada)
|   |
Assessment of relation between BODE index and quality of life, nutritional status, and C-reactive protein in patients with COPD
Y. Havlucu (Hatay, Turkmenistan)
| |
Psychologic impairment according to GOLD COPD staging for patients in a primary care setting
V. Tsagaraki, M. Sophia, M. Toumbis (Zographou, Athens, Greece)
| |
Spirometries in patients at a high risk of developing chronic obstructive pulmonary disease in general practices in Switzerland
D. Miedinger, A. Linz, C. Buess, P. N. Chhajed, M. Tamm, J. D. Leuppi (Basel, Zuerich, Switzerland)
| |
Easy-use device for screening COPD in primary care: prospective validation study
P. Frith, A. Crockett, J. Beilby, D. Marshall, R. Attewell (Adelaide, South Australia, Sydney, New South Wales, Canberra, Australian Capital Territory, Australia)
| |
Aerosolotherapy in stable chronic obstructive pulmonary disease (COPD) – common inhalers use ability and usefulness of PIF measurement in choice of inhalers
A. Obojski, B. Chmielowicz, M. Wujczyk, B. Wencka, R. Dobek (Wroclaw, Poland)
| |
Factors associated with seeking care for COPD: a qualitative analysis
N. Giardino, L. Chan, S. Borson, J. Curtis, F. Martinez, I. Liberzon (Ann Arbor, MI, Bethesda, MD, Seattle, WA, United States Of America)
| |
Assisted early discharge for COPD exacerbations in Bradford
R. Mustafa, D. Saralaya, K. Taite, R. Daw, S. Daughtry, W. Passant, T. Lightowler, K. Johnson (Bradford, United Kingdom)
| |
Is COPD diagnosis in primary care performed according to guidelines?
K. Lisspers, B. Stallberg, M. Arne, G. Johansson, K. Svardsudd, C. Janson (Uppsala, Sweden)
| |
Prevalence of COPD in the general population according to cardiovascular risk factors
J. B. Soriano, A. Agusti, M. Castresana, G. Frontera, J. Llobera, P. Martinez-Camblor, F. Rigo (Bunyola, Mallorca, Spain)
| |
Health status and utility for COPD patients: a questionnaire-based study
J. O‘Reilly, L. Rice (Liverpool, Uxbridge, United Kingdom)
| |
Adaptation rate between COPD treatment in clinical practice and guidelines recommendations
A. J Madueno Caro, J. A. Peculo Carrasco, L. J. Antonio, D. L. Isabel, G. Elena (Cádiz, Cadiz, Spain)
| |
Vitamin D (25OHD3) and parathyroid hormone (PTH) status in patients with COPD
S. Fernández, J. Oriol, C. Castaño, J. A. Gonzalez, G. Beltran, J. Aguilar, M. J. Peña, N. Galofre (Badalona, Barcelona, Spain)
| |
Detecting patients at risk of developing airflow obstruction in general population
M. V. Lopez Varela, T. Anido, M. Mamchur, E. Pacheco, C. Alvez, F. Gimenez, A. Tempone, K. Fagundez (Montevideo, Uruguay)
| |
The AIRTEM project: home telemonitoring of patients affected by COPD and chronic respiratory failure
E. Battaglia, E. Madonini, S. Amaducci (Milan, Italy)
| |